Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2024-10-08 · amended | 0.00% | no change |
| Evo Fund2024-10-08 · amended | 25.06% | -2.17pp |
| Evolution Capital Management LLC2024-09-27 · amended | 0.00% | no change |
| Evo Fund2024-09-27 · amended | 27.23% | -2.40pp |
| Evolution Capital Management LLC2024-09-26 · amended | 0.00% | no change |
| Evo Fund2024-09-26 · amended | 29.63% | -5.32pp |
| Evolution Capital Management LLC2024-09-25 · amended | 0.00% | no change |
| Evo Fund2024-09-25 · amended | 34.95% | -3.02pp |
| Osamu Nureki2024-09-25 | 3.58% | -1.53pp |
| Evolution Capital Management LLC2024-09-20 · amended | 0.00% | no change |
| Evo Fund2024-09-20 · amended | 37.97% | -1.02pp |
| Evolution Capital Management LLC2024-09-17 · amended | 0.00% | no change |
| Evo Fund2024-09-17 · amended | 38.99% | -0.44pp |
| Evolution Capital Management LLC2024-09-12 · amended | 0.00% | no change |
| Evo Fund2024-09-12 · amended | 39.43% | -1.29pp |
| Evolution Capital Management LLC2024-09-10 · amended | 0.00% | no change |
| Evo Fund2024-09-10 · amended | 40.72% | -0.42pp |
| SBI Investment Co., Ltd.2024-09-09 · amended | 2.09% | -0.49pp |
| SBI SECURITIES Co., Ltd.2024-09-09 · amended | 2.28% | -0.52pp |
| SBI Investment Co., Ltd.2024-09-09 · amended | 2.58% | -0.19pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.